This topic contains a solution. Click here to go to the answer

Author Question: The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to ... (Read 89 times)

arivle123

  • Hero Member
  • *****
  • Posts: 569
The client is receiving warfarin (Coumadin). Which laboratory result will the nurse monitor to evaluate the therapeutic response?
 
  1. WBC
  2. PT and INR
  3. BNP
  4. aPTT

Question 2

The client is receiving heparin (Hep-Lock). The nurse will monitor which laboratory results to evaluate therapeutic response?
 
  1. INR
  2. aPTT
  3. BNP
  4. PT



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

2

Rationale 1: WBC is used to determine infection.
Rationale 2: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 3:BNP is incorrect because this lab result does not pertain to clotting.
Rationale 4:aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Global Rationale: PT and INR should be monitored for a client receiving warfarin (Coumadin) therapy. PT is incorrect because it should be monitored with INR for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting. aPTT is incorrect because this should be monitored for a client receiving heparin therapy.

Answer to Question 2

2

Rationale 1:INR is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.
Rationale 2: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used.
Rationale 3: BNP or beta natriuretic peptide is used for the severity rate of congestive heart failure.
Rationale 4:PT is incorrect because it should be monitored for a client receiving warfarin (Coumadin) therapy.

Global Rationale: To avoid serious adverse effects, drug therapy with coagulation-modifier drugs is individualized to each patient, and must be carefully monitored. For heparin, the activated partial thromboplastin time (aPTT) is used. PT and INRare incorrect because they should be monitored for a client receiving warfarin (Coumadin) therapy. BNP is incorrect because this lab result does not pertain to clotting.




arivle123

  • Member
  • Posts: 569
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

For a complete list of videos, visit our video library